SLPSimulations Plus, Inc.
17.54USD+2.69%Mkt Cap: 358.24M USDP/E: Last update: 2026-06-01

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…

Indicators:|

Key Statistics

Company
Market Cap358.24M USD
Enterprise Value304.19M USD
Revenue (TTM)80.53M USD
Gross Profit46.22M USD
Net Income (TTM)-64.72M USD
Revenue/Share4.000 USD
Last Price17.54 USD
Fiscal Year EndAug 2025
MR QuarterFeb 2026
Employees212
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN
Valuation
P/E (Trailing)
P/E (Forward)18.56
PEG9.88
EV/EBITDA21.79
EV/Revenue3.78
P/S4.29
P/B2.58
EPS (TTM)-3.12
EPS (Forward)0.92
52W Range
11.0930% of range32.32
52W High32.32 USD
52W Low11.09 USD
Profitability
Gross Margin58.38%
Oper. Margin23.18%
EBITDA Margin17.34%
Profit Margin-81.74%
ROE-51.86%
ROA-49.05%
Growth
Revenue Growth8.30%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF18.13M USD
CapEx (TTM)3.72M USD
FCF Margin21.33%
FCF Yield4.80%
Net Debt-41.33M USD
Net Debt/EBITDA-2.96
Balance Sheet
Debt/Equity0.00
Current Ratio5.47
Quick Ratio5.26
Book Value/Sh6.621 USD
Cash/Share2.071 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJul 29, 2024
Pay DateAug 5, 2024
Splits
Last Split2:1
Split DateOct 2, 2007
Analyst Consensus
Rating
Target (Mean)23.67 USD
Target Range16.00 USD31.00 USD
# Analysts3
Ownership
Shares Out.20.21M
Float16.71M
Insiders17.29%
Institutions82.94%
Short Interest
Short Ratio3.4d
Short % Float9.70%
Short % Out.6.88%
Shares Short1.39M
Short (prev mo.)1.23M
Technical
SMA 5013.90 (+26.2%)
SMA 20015.53 (+12.9%)
Beta1.28
S&P 52W Chg27.70%
Avg Vol (30d)330.23K
Avg Vol (10d)226.85K
Technical Indicators
RSI (14)69.7
MACD0.5409
MACD Signal0.3199
MACD Hist.+0.2210
BB Upper17.31 USD
BB Middle15.04 USD
BB Lower12.77 USD
BB Width30.14%
ATR (14)0.8660 USD
Vol Ratio (20d)0.51x